This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Analysts' Actions: AMZN, FTR, GRPN

NEW YORK ( TheStreet) -- CHANGE IN RATINGS (AMZN - Get Report) was downgraded at Bank of America/Merrill Lynch to Neutral. Valuation call, based on a $235 price target, BofA/Merrill said.

Abercrombie & Fitch (ANF) was upgraded at Brean Murray from Hold to Buy. $65 price target. Estimates also boosted, as business trends appear to have bottomed, Brean Murray said.

Addus Homecare Corp. (ADUS) was upgraded to hold at TheStreet Ratings.

Alliant Techsystems (ATK) was upgraded at JP Morgan from Neutral to Overweight. Valuation call, as the stock has seen a sharp selloff in recent weeks, JP Morgan said.

Concho Resources (CXO) was upgraded at Deutsche Bank to Buy from Hold. $131 price target. Concho has underperformed its peers 13% year to date on unwarranted concerns, Deutsche Bank said.

Cytec Industries (CYT) was downgraded at Citigroup to Neutral from Buy. $66 price target. Rally suggests the coatings valuation bar has been raised, Citigroup said.

Exelis (XLS) was downgraded at JP Morgan to Neutral. Valuation call, as the stock is up 38% year-to-date, JP Morgan said.

Frontier (FTR - Get Report) was upgraded at Nomura from Neutral to Buy. $5 price target. Stock is attractively valued, with a 10% dividend and 20% free cash flow yield, Nomura said.

GAIN Capital Holdings (GCAP) was downgraded to sell at TheStreet Ratings.

Groupon (GRPN - Get Report) was downgraded from Hold to Sell at Stifel Nicolaus. Business model remains a work in progress, Stifel Nicolaus said.

Groupon (GRPN - Get Report) was downgraded from Buy to Neutral at Bank of America/Merrill Lynch. Restatement undermines investor confidence, BofA/Merrill said. $20 price target.

Kohl's (KSS) was upgraded at JP Morgan from Underweight to Neutral. $55 price target. Stock has underperformed its peers over the past five months, JP Morgan said.

Linear Technology (LLTC) was downgraded at UBS to Neutral from Buy. $35 price target. Valuation ahead of fundamentals, UBS said.

PAREXEL International (PRXL) was downgraded at Sterne Agee to Underperform from Neutral. $24.50 price target. Guidance unlikely to support recent outperformance, Sterne Agee said.

PVH (PVH) was upgraded at Credit Suisse from Neutral to Outperform. Demand is improving in the U.S. and Europe, Credit Suisse said. $105 price target.

Regeneron Pharmaceuticals (REGN) was initiated with a Buy rating at Goldman Sachs. $144 price target. Anticipate continued robust uptake of new drug Eylea, Goldman said.

SL Green Realty (SLG) was downgraded at UBS to Neutral from Buy. $80 price target. Lacking meaningful positive catalysts, UBS said.
1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
FTR $4.90 0.10%
GRPN $2.88 0.35%
AMZN $675.55 0.66%
TSLA $228.63 4.80%
YHOO $32.67 -0.88%


Chart of I:DJI
DOW 17,803.97 -9.42 -0.05%
S&P 500 2,088.87 -0.27 -0.01%
NASDAQ 5,116.1430 +13.3350 0.26%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs